Article Data

  • Views 1213
  • Dowloads 146

Letters to the Editor

Open Access

Emerging etiopathogenic connections between Arg399Gln polymorphism and systemic malignancies besides their etiological role in endometrial carcinomas

  • S. Kapoor1,*,

1Private practise, Mechanicsville, VA, USA

DOI: 10.12892/ejgo201206565 Vol.33,Issue 6,November 2012 pp.565-566

Published: 10 November 2012

*Corresponding Author(s): S. Kapoor E-mail: shailendrakapoor@yahoo.com

Cite and Share

S. Kapoor. Emerging etiopathogenic connections between Arg399Gln polymorphism and systemic malignancies besides their etiological role in endometrial carcinomas. European Journal of Gynaecological Oncology. 2012. 33(6);565-566.

References

[1] Samulak D., Romanowicz-Makowska H., Smolarz B., Kulig A., Sporny S.: “Association between Arg399Gln polymorphism of Xray repair cross-complementing 1 (XRCC1) gene and sporadic endometrial cancer in the Polish population”. Eur. J. Gynaecol. Oncol., 2011, 32, 491.

[2] Roszak A., Lianeri M., Jagodzinski P.P.: “Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma”. Int. J. Biol. Markers., 2011, 26, 216. Doi 10.5301/JBM.2011.8581.

[3] Huang Y., Li L., Yu L.: “XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis”. Mutagenesis, 2009, 24, 331. Epub 2009 May 22.

[4] Duman N., Aktan M., Ozturk S., Palanduz S., Cakiris A., Ustek D.: “Investigation of Arg399Gln and Arg194Trp Polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia”. Genet. Test. Mol. Biomarkers, 2012, 16, 287. Epub 2011 Nov. 22.

[5] Tumer T.B., Yilmaz D., Tanrikut C., Sahin G., Ulusoy G., Arinç E.: “DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia”. Leuk. Res., 2010, 34, 1275. Epub 2010 Apr 14.

[6] Engin A.B., Karahalil B., Karakaya A.E., Engin A.: “Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population”. Arh Hig Rada Toksikol., 2011, 62, 207, doi: 10.2478/10004-1254-62-2011-2098.

[7] Sreeja L., Syamala V.S., Syamala V., Hariharan S., Raveendran P.B., Vijayalekshmi R.V. et al.: “Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India”. J. Cancer Res. Clin. Oncol., 2008, 134, 645. Epub 2007 Oct 19.

[8] Wei B., Zhou Y., Xu Z. et al.: “XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis”. Prostate Cancer Prostatic Dis., 2011, 14, 225. Doi 10.1038/pcan.2011.26. Epub 2011 Jun 7.

Submission Turnaround Time

Top